For citations:
Radaeva O.A., Balykova L.A., Zaslavskaya K.Ya., Taganov A.V., Bely P.A., Kostina Yu.A., Negodnova E.V., Mashnina S.V., Bessheinov D.D., Iskandyarova M.S., Eremeev V.V., Chumakov N.M. STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD. Pharmacy & Pharmacology. 2022;10(2):217-228. https://doi.org/10.19163/2307-9266-2022-10-2-217-228